贝塔血病:展望未来,解决未满足的需求和挑战
1Thalassaemia International Federation, Nicosia, Cyprus.
Annals of the New York Academy of Sciences
|January 13, 2024
概括
新的血病疗法提供了希望,但获取和负担能力仍然是关键挑战. 改善患者护理需要解决系统性弱点,并确保全球所有患者平等获得治疗.
科学领域:
- 血液学 血液学 血液学
- 公共卫生 公共卫生
- 卫生政策 卫生政策
背景情况:
- 血病管理正在推进新型疗法,但目前的治疗方法还不足以提供最佳的生活质量.
- 在患者护理获取和结果方面,全球仍然存在重大不平等.
- 现有的治疗方法在可访问性,可负担性和患者坚持性方面面临挑战.
研究的目的:
- 确定系统性要求,以改善血病护理,并促进采用新疗法.
- 分析目前的血病服务供应缺口及其潜在原因.
- 提出加强资源管理,患者支持和专业专业知识的战略.
主要方法:
- 对当前的血病管理挑战进行定性分析.
- 对影响医疗保健可及性,负担能力和质量的因素的审查.
- 识别在政治和财务支持的系统性弱点,以护理血病.
主要成果:
- 服务供应赤字源于政治/财务支持不足,资源配给和流行病学数据缺乏.
- 系统性改进需要加强资源管理,患者支持组织和专业教育.
- 医疗产品和技术的可负担性和可用性对于治疗治疗的广泛采用至关重要.
结论:
- 实现更好地获得创新和优质的血病护理,包括治愈,需要所有利益相关者的协作努力.
- 解决系统性弱点对于公平的全球色素素病患者护理至关重要.
- 患者支持,心理社会福祉和提高专业专业知识是推动血病管理的重要组成部分.
更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.5K
相关概念视频
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K
